Rebuilding trust across a fragmented healthcare landscape demands that payers and providers alike move beyond transactional relationships and prioritize transparency, empathy, and tailored communication. The post Healthcare’s Trust Crisis Is an Experience Crisis appeared first on MedCity News.

The U.S. Department of Health and Human Services (HHS) is rolling back several health IT certification requirements that could reduce certification costs for technology developers. But they may leave hospitals and health systems holding more responsibility for evaluating the safety and performance of the AI tools they purchase. The post Looser Health IT Certification Requirements Shift Oversight to Health Systems appeared first on MedCity News.

Health tech companies made several major funding announcements in October. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in October appeared first on MedCity News.

In this episode, we’re joined by Dr. Rani Aravamudhan, senior medical director of Artemis at Nomi Health. We discuss Nomi Health’s new research on endometriosis. The post MedCity FemFwd: The Gaps in Endometriosis Care appeared first on MedCity News.

Inovio’s Voceryq will compete with a Precigen product that last year became the first FDA-approved drug for recurrent respiratory papillomatosis, or RRP. While the two immunotherapies carry the same $460,000 list price, Inovio executives claim their product has another competitive advantage. The post Inovio’s DNA-Based Immunotherapy Lands Speedy FDA Nod for Rare Type of Tumor appeared first on MedCity News.

The federal government is testing whether artificial intelligence can help Medicare identify unnecessary medical care, speed up the prior authorization process, and reduce healthcare spending. But a new report based on evidence recovered from a lawsuit raises concerns about the AI experiment. The post 7 Potential Problems with Medicare’s AI Prior Authorization Experiment  appeared first on MedCity News.

As health system dealmaking stays steady in 2026, Integris Health is joining Risant Health to accelerate value-based care. The partnership represents an integration of Risant Health’s capabilities into Integris’ existing system, rather than a traditional merger. The post Integris Health to Join Risant Health as Health System Dealmaking Stays Active appeared first on MedCity News.

Why should Medicare determine who is qualified to provide remote monitoring by asking who employs the nurse, rather than who is accountable for the patient’s care? The post CMS Is Regulating the Wrong Thing — Here’s How to Fix Remote Patient Monitoring Without Losing the Care appeared first on MedCity News.

[Sponsored] BTK inhibitor has become an important treatment option for certain B-cell malignancies. The post How Innovation in BTK Inhibitor Development Is Improving Treatment Outcomes appeared first on MedCity News.

Companies aren’t slowing down to ask if AI is ready for mental health; they’re racing to build it in. Encoding the same unexamined standards into these tools means repeating the systemic issues marginalized groups have lived with for far too long. The post Mental Health Care Was Never Built for Everyone — AI Won’t Fix That appeared first on MedCity News.

Midstream’s Series A round was led by Valtruis, and included participation from Andreessen Horowitz (a16z), Foundry and CommonSpirit Ventures. The post Midstream Health Snags $20M to Provide Health Systems More Financial Stability appeared first on MedCity News.

Setara Biosciences’ lead program is a potential treatment for the rare neuromuscular disorder Charcot-Marie-Tooth disease type 2C and the prevalent condition overactive bladder. This small molecule came from Actio Biosciences, which was recently acquired by Jazz Pharmaceuticals. The post Rare Disease Biotech Setara Starts Out With $90M and a Lead Drug in the Clinic appeared first on MedCity News.

Medical Microinstruments (MMI) has raised $125 million in Series D financing to expand the reach of its Symani Surgical System and investigate new applications for microsurgery, including an experimental approach to treat Alzheimer’s disease. The post MMI Raises $125M to Expand Robotic Microsurgery and Explore New Treatments appeared first on MedCity News.

One question on everyone’s mind is what the impact of the midterm elections will be on the US healthcare system in the near and long term – here are 3 possible outcomes The post What the Midterms Mean for Healthcare and the Investors Betting on It appeared first on MedCity News.

An employer that treats board disclosure, community benefit reporting, and contracting terms as three separate conversations is missing that they are the same conversation. The post Prestige Is a Business Model appeared first on MedCity News.